Healthcare & Life Sciences
Sentaur Biosciences
Israel
activeseries-a
series-a
Stage
1
Investors
About
Sentaur Biosciences develops antibodies to specifically target and eliminate senescent cells, using a unique MS-based discovery method to identify novel targets on the surface of these cells.
Explore Sentaur Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.